Menu

Tandem Diabetes Care, Inc. TNDM

Full chart Compare
Set alert

Price alert · TNDM

All alert types
18.71 USD +0.54 (+2.97%)

At closeNov 10, 2026, 4:20 PM EST

18.71 0.00 0.00%

After hours · Nov 10, 4:20 PM ET

17.58 Day range 18.83
12.26 52-week range 29.65
YTD
-14.88%
1 year
+14.29%
Market cap
1.31B
Revenue (ttm)
1.08B
Profit margin
-4.58%
EPS (ttm)
-0.70
Shares out
69.79M
Forward P/E
139.77
YTD return
-14.88%
1-year return
+14.29%
Volume
2.72M
Avg volume
2.13M
Open
17.77
Previous close
18.17
Day's range
17.58 – 18.83
52-week range
12.26 – 29.65
Beta
1.59
Analysts
Buy
Price target
27.38 (+46.3%)
Earnings date
Feb 18, 2027

5D +0.13 (+0.70%)

1618WedThuFriMonTue18.71

Key statistics

Enterprise value
1.56B
PEG ratio
0.00
Price / sales
1.21
Price / book
9.66
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
13.80%
Free cash flow
-65.56M
Total cash
443.08M
Total debt
736.54M
Return on equity
-36.73%
Short % of float
28.94%
50-day average
17.58
200-day average
18.86

Financials — quick view

All financials
TNDM Revenue — quarterly 283.69M
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
TNDM Net income — quarterly -7.08M
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
TNDM EPS — quarterly -0.10
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026

Earnings

TNDM recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 18, 2027Dec 30, 20260.13———
Nov 5, 2026Sep 30, 2026-0.24533-0.10+0.15+59.24%
Aug 6, 2026Jun 30, 2026-0.32074-0.31+0.01+3.35%
May 7, 2026Mar 31, 2026-0.46-0.30+0.16+34.78%
Feb 19, 2026Dec 31, 2025-0.05-0.01+0.04+80.00%
Nov 6, 2025Sep 30, 2025-0.31-0.310.000.00%

Upgrades / downgrades

TNDM analyst upgrades and downgrades
DateFirmActionFromTo
Nov 6, 2026BarclaysmainEqual-WeightEqual-Weight
Nov 6, 2026Wells FargomainOverweightOverweight
Oct 7, 2026Barclaysinit—Equal-Weight
Sep 30, 2026CitigroupmainNeutralNeutral
Sep 24, 2026Truist SecuritiesmainBuyBuy
Aug 21, 2026William Blairinit—Outperform

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, it offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Sector
Healthcare
Industry
Medical Devices
Country
United States

News

Your note

Sign in to keep a note on TNDM — it syncs with the Stock Master app.

Insider holders

TNDM insider holders
InsiderRelationLatest transactionDateShares held
ALLEN DICK PRetiredConversion of Exercise of derivative securityMay 20, 202650,903
BLICKENSTAFF KIM DDirectorSaleNov 20, 20240
CARPENTER RICKChief Technology OfficerConversion of Exercise of derivative securityAug 13, 202632,148
GASSER ELIZABETH ANNEOfficerConversion of Exercise of derivative securityAug 13, 202634,505
HANSEN SHANNON MARIEOfficerConversion of Exercise of derivative securityAug 13, 202633,585
MORRISON SUSAN MOfficerConversion of Exercise of derivative securityAug 13, 202652,788

Institution ownership

TNDM institution ownership
Holder% heldSharesValueReported
Blackrock Inc.16.60%11,583,125216.72MJun 29, 2026
Sessa Capital IM, L.P.7.31%5,100,00095.42MJun 29, 2026
Vanguard Portfolio Management LLC6.16%4,299,66780.45MJun 29, 2026
First Light Asset Management, LLC4.85%3,383,55363.31MJun 29, 2026
Vanguard Capital Management LLC4.44%3,096,53657.94MJun 29, 2026
State Street Corporation4.09%2,851,64653.35MJun 29, 2026

Fund ownership

TNDM fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Small-Cap ETF5.93%4,140,27877.46MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.13%2,186,91840.92MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.58%1,803,94733.75MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.25%1,570,01929.38MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund1.29%901,46716.87MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund1.13%788,50914.75MJun 29, 2026